Diagen company is Contract Research Organization specialized for research on active peptides and other active molecules for use in pharmaceuticals. We are working and cooperating with several Institutes and Universities as well we have worked on several development projects for some of the largest Pharmaceutical companies.

We are oriented in Discovery, Research and Development of Pharmaceutical active molecules.

During our work we have been able to discover in human body a special protein BPC (Body Protecting Compound) which is responsible through its mechanism to enhance natural healing process. Within our research we were able to isolate and determine composition and sequence of natural BPC and developed synthetic BPC 157 Stable version which is Worldwide Patented by our company.

We have together with our partners physicians performed more that 200 animal studies with BPC 157 Stable for treating different diseases. Based on positive outcome of our studies on animals we have determined main Therapeutic areas of BPC 157 Stable: Gastrointestinal tract diseases, Neurology, Enhanced Body Healing, Cardiovascular, Antivirus, and Ophthalmology.

Since BPC 157 Stable demonstrated comparable healing activities as natural human BPC protein which acts as a human own natural healing agent in the body we foresee huge potential for use of BPC 157 Stable for healing different complex and difficult to heal diseases in humans and animals.

We see our mission to enable BPC157 to be available as a Pharmaceutical product to patients with difficult to heal diseases however with approach that BPC 157 Stable promotes and substantially enhances body’s own healing process. With BPC 157 Stable we would like to give opportunity to patients for healing and curing their diseases and provide better quality of their life worldwide.

Since our company as CRO has limited resources we are welcoming all potential investors and companies who would be interested to share our goals to contact us for acquiring our Patent rights or licensing rights for BPC 157 Stable for human Pharmaceutical use, Veterinary use or Supplement use.